stoxline Quote Chart Rank Option Currency Glossary
Ekso Bionics Holdings, Inc. (EKSO)
1.75  0 (0%)    12-01 16:00
Open: 1.77
High: 1.7799
Volume: 30,932
Pre. Close: 1.75
Low: 1.72
Market Cap: 25(M)
Technical analysis
2023-12-01 4:19:36 PM
Short term     
Mid term     
Targets 6-month :  2.09 1-year :  2.44
Resists First :  1.78 Second :  2.09
Pivot price 1.53
Supports First :  1.14 Second :  0.75
MAs MA(5) :  1.7 MA(20) :  1.49
MA(100) :  1.05 MA(250) :  1.31
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  92.3 D(3) :  91.5
RSI RSI(14): 78
52-week High :  1.87 Low :  0.62
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ EKSO ] has closed below upper band by 10.4%. Bollinger Bands are 54.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.79 - 1.8 1.8 - 1.8
Low: 1.67 - 1.68 1.68 - 1.69
Close: 1.74 - 1.75 1.75 - 1.76
Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Headline News

Tue, 28 Nov 2023
Ekso Bionics Holdings Inc (EKSO) is higher by 16.44% in a Week, Should You Hold? - InvestorsObserver

Fri, 24 Nov 2023
Medical Exoskeleton Market to grow by USD 974.84 million from ... - Yahoo Finance

Wed, 22 Nov 2023
Is Ekso Bionics Holdings Inc (EKSO) a Stock to Watch After Gaining 10.79% This Week? - InvestorsObserver

Thu, 16 Nov 2023
Ekso Bionics to Participate at Centers for Medicare & Medicaid ... - GlobeNewswire

Mon, 06 Nov 2023
Marin County's Ekso Bionics expects sales boost from new Medicare ... - North Bay Business Journal

Thu, 02 Nov 2023
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Instruments & Supplies
Shares Out 14 (M)
Shares Float 13 (M)
Held by Insiders 18.3 (%)
Held by Institutions 15.3 (%)
Shares Short 34 (K)
Shares Short P.Month 40 (K)
Stock Financials
EPS -1.13
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.07
Profit Margin -89.3 %
Operating Margin -63.7 %
Return on Assets (ttm) -28.6 %
Return on Equity (ttm) -69.2 %
Qtrly Rev. Growth 38.4 %
Gross Profit (p.s.) 0
Sales Per Share 1.19
EBITDA (p.s.) -1.05
Qtrly Earnings Growth 0 %
Operating Cash Flow -14 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -1.57
PEG Ratio 0
Price to Book value 1.63
Price to Sales 1.46
Price to Cash Flow -1.77
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android